Related Experiment Video
Updated: Oct 12, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J Moss1, Stefan W Ryter2, Ivan O Rosas1
1Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA; email: benjamin.moss@bcm.edu, ivan.rosas@bcm.edu.
Idiopathic pulmonary fibrosis (IPF) pathogenesis involves recurrent alveolar epithelial cell (AEC) injury and aberrant repair. Novel bioinformatics tools help uncover cell-specific mechanisms driving this profibrotic lung disease.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Bioinformatics
Background:
- Idiopathic pulmonary fibrosis (IPF) pathogenesis is complex, involving multiple cell types and signaling pathways.
- Recurrent alveolar epithelial cell (AEC) injury, influenced by genetic and environmental factors, leads to senescence and dysregulated repair.
- This aberrant repair process involves interactions between AECs and other cells, promoting fibroblast activation.
Purpose of the Study:
- To review the pathogenesis of IPF.
- To highlight the role of novel bioinformatics tools in understanding IPF.
- To identify cell-specific mechanisms and cell-cell interactions driving the profibrotic niche in IPF.
Main Methods:
- Review of existing literature on IPF pathogenesis.
- Analysis of recent single-cell RNA sequencing studies in IPF lungs.
- Application of bioinformatics tools to discover disease pathways and cell interactions.
Main Results:
- Single-cell RNA sequencing supports an epithelial injury model for IPF.
- A novel AEC type with aberrant basal cell characteristics was identified.
- These aberrant AECs may disrupt normal repair and promote a profibrotic phenotype.
Conclusions:
- Epithelial cell injury and aberrant repair are central to IPF pathogenesis.
- Novel bioinformatics approaches are crucial for dissecting complex cell-cell interactions in IPF.
- Understanding these mechanisms can reveal new therapeutic strategies for IPF.
More Related Videos
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pneumonia II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...